MedTrace Logo

McNeill Dysphagia Therapy Program Combined With Transcranial Magnetic Stimulation

NCT06184711 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-28

No results posted yet for this study

Summary

This study aimed to investigate the effectiveness of the McNeill Dysphagia Therapy (MDTP) programme combined with Transcranial Magnetic Stimulation (TMS) in individuals with post-stroke dysphagia.

Conditions

Interventions

DEVICE

Transcranial Magnetic Stimulation+McNeill Dysphagia Therapy Programme

The McNeill Dysphagia Therapy programme (MDTP) combined with Transcranial Magnetic Stimulation (TMS) will be applied to the first experimental group.

DEVICE

Sham Transcranial Magnetic Stimulation +McNeill Dysphagia Therapy Programme

The McNeill Dysphagia Therapy programme (MDTP) combined with sham Transcranial Magnetic Stimulation (TMS) will be applied to the sham comparator group.

DEVICE

Transcranial Magnetic Stimulation

Only Transcranial Magnetic Stimulation (TMS) will be applied to the second experimental group.

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

  • Kübra Nur ŞİMŞEK · Ankara City Hospital Bilkent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-29
Primary Completion
2025-12-29
Completion
2025-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06184711 on ClinicalTrials.gov